These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 20600486
1. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer. Kalthoff D, König P, Trapp S, Beer M. Vaccine; 2010 Aug 16; 28(36):5871-7. PubMed ID: 20600486 [Abstract] [Full Text] [Related]
2. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge. Chowdhury SI, Wei H, Weiss M, Pannhorst K, Paulsen DB. Vaccine; 2014 Sep 03; 32(39):4909-15. PubMed ID: 25066735 [Abstract] [Full Text] [Related]
3. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype. Muylkens B, Meurens F, Schynts F, de Fays K, Pourchet A, Thiry J, Vanderplasschen A, Antoine N, Thiry E. Vet Microbiol; 2006 Mar 31; 113(3-4):283-91. PubMed ID: 16321480 [Abstract] [Full Text] [Related]
4. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine. Campos FS, Dezen D, Antunes DA, Santos HF, Arantes TS, Cenci A, Gomes F, Lima FE, Brito WM, Filho HC, Batista HB, Spilki FR, Franco AC, Rijsewijk FA, Roehe PM. Vet Microbiol; 2011 Feb 24; 148(1):18-26. PubMed ID: 20828945 [Abstract] [Full Text] [Related]
8. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad". El-Kholy AA, Rady DI, Abdou ER, Elseafy MM, Abdelrahman KA, Soliman H. J Virol Methods; 2013 Dec 24; 194(1-2):74-81. PubMed ID: 23962750 [Abstract] [Full Text] [Related]
9. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1. Wernike K, Hoffmann B, Kalthoff D, König P, Beer M. J Virol Methods; 2011 Jun 24; 174(1-2):77-84. PubMed ID: 21458493 [Abstract] [Full Text] [Related]
10. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain. König P, Beer M, Makoschey B, Teifke JP, Polster U, Giesow K, Keil GM. Vaccine; 2003 Dec 12; 22(2):202-12. PubMed ID: 14615147 [Abstract] [Full Text] [Related]
16. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E. Comp Immunol Microbiol Infect Dis; 2005 Mar 12; 28(2):155-66. PubMed ID: 15582691 [Abstract] [Full Text] [Related]
18. Bovine herpesvirus-1: evaluation of genetic diversity of subtypes derived from field strains of varied clinical syndromes and their relationship to vaccine strains. Fulton RW, d'Offay JM, Eberle R, Moeller RB, Campen HV, O'Toole D, Chase C, Miller MM, Sprowls R, Nydam DV. Vaccine; 2015 Jan 15; 33(4):549-58. PubMed ID: 25454086 [Abstract] [Full Text] [Related]
19. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination. Makoschey B, Beer M. Berl Munch Tierarztl Wochenschr; 2007 Jan 15; 120(11-12):480-2. PubMed ID: 18085158 [Abstract] [Full Text] [Related]
20. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models. Ferrer MF, Del Médico Zajac MP, Zanetti FA, Valera AR, Zabal O, Calamante G. Viral Immunol; 2011 Aug 15; 24(4):331-9. PubMed ID: 21830904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]